Estrace combined with Premarin

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Progesterone Receptor Assay Positive Other Serious 12/3/1999 64 Female 12/30/2005 United States
Primary
Secondary
Neoplasm Malignant Other Serious Female 1/11/2006 Consumer United States
Primary
Secondary
Injury Hospitalization 4/1/2004 60 Female 157 lb 1/13/2006 Lawyer United States
Primary
Concomitant
Vomiting Hospitalization 9/11/2002 54 Female 154 lb 1/23/2006 Lawyer United States
Primary
Concomitant
Spinal Osteoarthritis Hospitalization 4/1/2004 60 Female 157 lb 1/30/2006 Physician United States
Primary
Concomitant
Progesterone Receptor Assay Positive Other Serious 3/19/2003 64 Female 154 lb 1/24/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 9/12/2002 63 Female 216 lb 1/31/2006 Consumer United States
Primary
Secondary
Depression Other Serious 1/1/2004 68 Female 121 lb 1/31/2006 Consumer United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 1/14/2002 54 Female 1/31/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Female 2/1/2006 Consumer United States
Primary
Secondary
Breast Cancer In Situ Other Serious Female 1/27/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 1/31/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 2/6/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 2/1/2006 United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 2/1/2006 Physician United States
Primary
Secondary
Concomitant
Stress Fracture Other Serious 7/1/2001 59 Female 154 lb 2/6/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 6/26/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/25/2002 64 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 6/10/1998 59 Female 2/6/2006 Consumer United States
Primary
Secondary
Ovarian Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/18/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/1997 56 Female 150 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 11/21/1995 61 Female 130 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/23/1998 46 Female 188 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/3/2002 56 Female 130 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2003 Female 12/23/2005 United States
Primary
Secondary
Transient Ischaemic Attack Other Serious 10/8/2003 63 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/1999 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/30/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/9/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/5/2005 64 Female 12/23/2005 United States
Primary
Secondary
Ovarian Cancer Other Serious 3/31/2003 63 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 4/29/2004 60 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/8/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Female Required Intervention Female 2/3/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/4/2002 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 1/21/1999 74 Female 2/7/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2004 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 2/14/2006 Lawyer United States
Primary
Secondary
Vitreous Haemorrhage Other Serious 2/21/2000 Female 2/14/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/8/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 8/26/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/16/1999 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1998 58 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/14/1999 64 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 11/1/2003 63 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 8/20/2002 56 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 5/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/22/2002 73 Female 2/17/2006 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 2/21/2001 55 Female 2/22/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/24/2000 Female 2/22/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 3/15/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/2/2003 62 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2000 63 Female 100 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/8/2003 66 Female 130 lb 2/27/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/25/2002 Female 2/28/2006 Consumer United States
Primary
Secondary
Non-hodgkin's Lymphoma Other Serious 2/11/2003 60 Female 150 lb 2/23/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 3/3/2006 Lawyer United States
Primary
Secondary
Metastases To Lymph Nodes Other Serious Female 2/28/2006 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 9/24/2003 58 Female 3/6/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/25/2002 Female 3/1/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/24/2000 Female 3/1/2006 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2004 Female 3/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 12/1/1999 65 Female 140 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 4/25/2002 Female 3/13/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 8/1/2000 52 Female 185 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/1998 61 Female 145 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/15/2001 49 Female 140 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 6/18/2003 64 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/1/2001 63 Female 158 lb 12/23/2005 United States
Primary
Secondary
Skin Cancer Other Serious 8/29/2003 55 Female 3/10/2006 United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 6/29/1995 57 Female 160 lb 3/10/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 3/13/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/25/2002 Female 3/14/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 3/17/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious Female 3/17/2006 United States
Primary
Secondary
Breast Cancer Other Serious 7/2/1998 63 Female 3/27/2006 Consumer United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 11/24/1995 69 Female 3/27/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 12/3/1996 68 Female 3/27/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2000 62 Female 3/28/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 12/4/1997 70 Female 3/28/2006 Lawyer United States
Primary
Secondary
Tumour Invasion Other Serious 12/12/2005 54 Female 125 lb 3/24/2006 Physician United States
Primary
Secondary
Concomitant
Oestrogen Receptor Assay Positive Other Serious 11/24/1995 69 Female 3/28/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 7/2/1998 63 Female 3/28/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 12/3/1996 68 Female 3/28/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 12/4/1997 70 Female 3/28/2006 United States
Primary
Secondary
Spleen Disorder Other Serious 10/5/2001 44 Female 178 lb 3/30/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 12/1/2000 62 Female 3/30/2006 United States
Primary
Secondary
Vaginal Removal Of Intrauterine Foreign Body Other Serious 9/22/1999 74 Female 128 lb 4/10/2006 Physician United States
Primary
Concomitant
Breast Cancer Other Serious Female 4/11/2006 Consumer United States
Primary
Secondary
Breast Cancer In Situ Other Serious 8/6/1998 63 Female 4/11/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/2/2001 64 Female 4/11/2006 Lawyer United States
Primary
Secondary
Weight Increased Hospitalization 10/13/1998 56 Female 172 lb 4/5/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 5/1/2000 Female 4/12/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2000 Female 4/12/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/2003 64 Female 4/12/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2002 Female 4/6/2006 Lawyer United States
Primary
Secondary
Tumour Necrosis Other Serious 44 Female 178 lb 4/7/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2004 Female 4/17/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 2/8/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/4/2002 Female 2/8/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2002 Female 4/11/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/12/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 6/2/2001 64 Female 4/12/2006 United States
Primary
Secondary
Vomiting Hospitalization 1/8/2001 54 Female 154 lb 4/20/2006 Physician United States
Primary
Concomitant
Oestrogen Receptor Assay Positive Other Serious 8/6/1998 63 Female 4/13/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2000 Female 4/13/2006 Lawyer United States
Primary
Secondary
Neoplasm Malignant Other Serious 12/14/1995 54 Female 190 lb 4/18/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 5/1/2000 Female 4/19/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2000 Female 4/19/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 4/24/2002 Female 5/1/2006 Consumer United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 4/21/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 4/24/2002 Female 4/25/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 5/7/2002 Female 5/3/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2000 Female 5/3/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 5/7/2002 Female 5/9/2006 Consumer United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 7/18/2003 57 Female 122 lb 5/5/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 5/1/2000 Female 5/12/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 12/1/1995 Female 5/12/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/24/2002 Female 4/28/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2000 Female 5/11/2006 United States
Primary
Secondary
Metastases To Lymph Nodes Other Serious 7/18/2003 55 Female 5/12/2006 United States
Primary
Secondary
Breast Cancer Required Intervention 4/29/2004 60 Female 3/7/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 8/1/2001 Female 3/7/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 6/26/2001 73 Female 5/24/2006 Consumer United States
Primary
Secondary
Breast Cancer In Situ Other Serious 9/15/1998 57 Female 5/24/2006 Consumer United States
Primary
Secondary
Breast Cancer In Situ Other Serious 7/17/1998 59 Female 5/24/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 5/30/1996 66 Female 5/25/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 6/26/2001 73 Female 5/24/2006 United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 7/17/1998 59 Female 5/24/2006 United States
Primary
Secondary
Splenic Lesion Other Serious 10/5/2001 44 Female 178 lb 5/24/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 5/28/2002 67 Female 130 lb 5/24/2006 United States
Primary
Secondary
Breast Cancer Other Serious 5/3/2001 63 Female 5/31/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 5/30/1996 66 Female 5/30/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/16/1999 Female 5/31/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 6/8/2006 Consumer United States
Primary
Secondary
Ovarian Cancer Other Serious 1/1/2003 Female 161 lb 6/8/2006 Consumer United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 5/3/2001 63 Female 6/1/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2002 60 Female 6/9/2006 Consumer United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 6/1/2006 Physician United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 5/30/1996 Female 6/2/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 7/18/2003 55 Female 6/9/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 5/28/2002 67 Female 130 lb 6/16/2006 Lawyer United States
Primary
Secondary

Drug Data